CF PharmTech, Inc. (02652) disclosed a repurchase of 33,000 H shares on 25 February 2026. The highest repurchase price reached HKD 37.90, and the lowest repurchase price was HKD 36.64, for an aggregate consideration of HKD 1.23 million.

After the transaction, the number of issued shares excluding treasury shares stood at 301.80 million, while treasury shares increased to 0.42 million, bringing the total share count to 302.22 million. The financial filing shows that the repurchased shares are held as treasury shares. The adjustment in treasury shares accounts for approximately 0.0109% of the existing issued shares (excluding treasury shares) prior to the repurchase.